AdaptHealth Corp. (AHCO)
- Previous Close
9.58 - Open
9.69 - Bid 9.90 x 100
- Ask 9.96 x 300
- Day's Range
9.59 - 9.96 - 52 Week Range
6.37 - 15.37 - Volume
1,047,955 - Avg. Volume
1,154,085 - Market Cap (intraday)
1.324B - Beta (5Y Monthly) 1.11
- PE Ratio (TTM)
-- - EPS (TTM)
-5.31 - Earnings Date May 7, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
11.85
AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.
adapthealth.comRecent News: AHCO
Performance Overview: AHCO
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AHCO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AHCO
Valuation Measures
Market Cap
1.32B
Enterprise Value
3.54B
Trailing P/E
--
Forward P/E
12.15
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.42
Price/Book (mrq)
0.91
Enterprise Value/Revenue
1.11
Enterprise Value/EBITDA
-16.81
Financial Highlights
Profitability and Income Statement
Profit Margin
-21.21%
Return on Assets (ttm)
3.34%
Return on Equity (ttm)
-37.24%
Revenue (ttm)
3.2B
Net Income Avi to Common (ttm)
-678.89M
Diluted EPS (ttm)
-5.31
Balance Sheet and Cash Flow
Total Cash (mrq)
81.61M
Total Debt/Equity (mrq)
156.45%
Levered Free Cash Flow (ttm)
176.41M
Research Analysis: AHCO
Company Insights: AHCO
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: AHCO
AHCO: What does Argus have to say about AHCO?
ADAPTHEALTH CORP has an Investment Rating of SELL; a target price of $9.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetAHCO: What does Argus have to say about AHCO?
ADAPTHEALTH CORP has an Investment Rating of SELL; a target price of $9.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetAHCO: What does Argus have to say about AHCO?
ADAPTHEALTH CORP has an Investment Rating of SELL; a target price of $9.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetAHCO: What does Argus have to say about AHCO?
ADAPTHEALTH CORP has an Investment Rating of SELL; a target price of $9.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice Target